Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Colucci

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
DICP : the Annals of Pharmacotherapy|October 1, 1991
Monitoring serum digoxin concentrations during digoxin immune Fab therapyM R Ujhelyi, R D Colucci, D M Cummings, et al.
Applied Optics|August 25, 2010
Adaptive optics for array telescopes using piston-and-tilt wave-front sensingP Wizinowich, B McLeod, M Lloyd-Hart, et al.
Annals of Internal Medicine|August 15, 1993
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxinM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Disposition of digoxin immune Fab in patients with kidney failureM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|November 1, 1995
Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptiveV Saano, P Glue, C R Banfield, et al.
Clinical Pharmacology and Therapeutics|September 1, 1995
Effects of felbamate on the pharmacokinetics of phenobarbitalP Reidenberg, P Glue, C R Banfield, et al.
Clinical Pharmacology and Therapeutics|October 1, 1995
Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepineJ A Hulsman, T W Rentmeester, C R Banfield, et al.
Anesthesiology|January 19, 2024
Reversal of Propofol-induced Depression of the Hypoxic Ventilatory Response by BK-channel Blocker ENA-001: A Randomized Controlled TrialSimone C Jansen, Maarten van Lemmen, Erik Olofsen, et al.
The Clinical Journal of Pain|September 22, 2007
Challenges in the development of prescription opioid abuse-deterrent formulationsNathaniel P Katz, Edgar H Adams, Howard Chilcoat, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
DICP : the Annals of Pharmacotherapy|October 1, 1991
Monitoring serum digoxin concentrations during digoxin immune Fab therapyM R Ujhelyi, R D Colucci, D M Cummings, et al.
Applied Optics|August 25, 2010
Adaptive optics for array telescopes using piston-and-tilt wave-front sensingP Wizinowich, B McLeod, M Lloyd-Hart, et al.
Annals of Internal Medicine|August 15, 1993
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxinM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Disposition of digoxin immune Fab in patients with kidney failureM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|November 1, 1995
Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptiveV Saano, P Glue, C R Banfield, et al.
Clinical Pharmacology and Therapeutics|September 1, 1995
Effects of felbamate on the pharmacokinetics of phenobarbitalP Reidenberg, P Glue, C R Banfield, et al.
Clinical Pharmacology and Therapeutics|October 1, 1995
Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepineJ A Hulsman, T W Rentmeester, C R Banfield, et al.
Anesthesiology|January 19, 2024
Reversal of Propofol-induced Depression of the Hypoxic Ventilatory Response by BK-channel Blocker ENA-001: A Randomized Controlled TrialSimone C Jansen, Maarten van Lemmen, Erik Olofsen, et al.
The Clinical Journal of Pain|September 22, 2007
Challenges in the development of prescription opioid abuse-deterrent formulationsNathaniel P Katz, Edgar H Adams, Howard Chilcoat, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pageof 5